日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

MicroRNAs associated with adenomyosis promote endometrial epithelial cell migration via MMP-2 and MMP-9 upregulation†

与子宫腺肌症相关的microRNA通过上调MMP-2和MMP-9促进子宫内膜上皮细胞迁移†

期刊:Biology of Reproduction
影响因子:3
doi:10.1093/biolre/ioaf231
Zipponi, Margherita; Camboni, Alessandra; Mamillapalli, Ramanaiah; Taylor, Hugh S; Dolmans, Marie-Madeleine
上皮细胞
MMP-9
多发性骨髓瘤
MMP-2
细胞生物学
发表日期：2026
文献求助 收藏

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

子宫颈低分化高级别神经内分泌癌的整合突变图谱分析

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2321898121
Bellone, Stefania; Jeong, Kyungjo; Halle, Mari Kyllesø; Krakstad, Camilla; McNamara, Blair; Greenman, Michelle; Mutlu, Levent; Demirkiran, Cem; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Zipponi, Margherita; Buza, Natalia; Hui, Pei; Raspagliesi, Francesco; Lopez, Salvatore; Paolini, Biagio; Milione, Massimo; Perrone, Emanuele; Scambia, Giovanni; Altwerger, Gary; Ravaggi, Antonella; Bignotti, Eliana; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Quick, Charles M; Angioli, Roberto; Terranova, Corrado; Zaidi, Samir; Nandi, Shuvro; Alexandrov, Ludmil B; Siegel, Eric R; Choi, Jungmin; Schlessinger, Joseph; Santin, Alessandro D
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

携带 MAP2K4 基因扩增的子宫平滑肌肉瘤在体内对新型 MAP2K4 抑制剂 PLX8725 敏感

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2023.03.009
Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Z Verzosa, Kevin Yang, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S Huang, Vaagn Andikyan, 
肿瘤
发表日期：2023
文献求助 收藏

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

聚（ADP-核糖）聚合酶抑制剂奥拉帕尼和泛 ErbB 抑制剂来那替尼在体外和体内对 HER2 过度表达的上皮性卵巢癌具有高度协同作用

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2023.01.015
Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Z Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏

Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

卵巢癌和子宫癌肉瘤在体内和体外均对 elimusertib 敏感，后者是一种新型共济失调毛细血管扩张症和 Rad3 相关 (ATR) 激酶抑制剂

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2022.12.003
Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Verzosa, Gary Altwerger, Elena Ratner, Gloria S Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E Schwartz, 
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏

Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Elimusertib (BAY1895344) 是一种新型 ATR 抑制剂，在子宫平滑肌肉瘤 ATRX 突变模型中表现出体内活性

期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2022.11.014
Justin Harold, Stefania Bellone, Diego D Manavella, Levent Mutlu, Blair McNamara, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Verzosa, Jungmin Choi, Weilai Dong, Natalia Buza, Pei Hui, Gary Altwerger, Gloria S Huang, Vaagn Andikyan, Mitchell Cla
肿瘤
发表日期：2023
文献求助 收藏

Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma"

关于“新型 ATR 抑制剂 Elimusertib (BAY1895344) 在 ATRX 突变的子宫平滑肌肉瘤模型中显示出体内活性”的更正

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.01.029
Harold, Justin; Bellone, Stefania; Manavell, Diego D; Mutlu, Levent; McNamara, Blair; Hartwich, Tobias Max Philipp; Zipponi, Margherita; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z; Choi, Jungmin; Dong, Weilai; Buza, Natalia; Hui, Pei; Altwerger, Gary; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Santin, Alessandro D
ATR
ATRX
TRX
发表日期：2023
文献求助 收藏

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression

曲妥珠单抗德鲁替康（DS-8201a）是一种靶向HER2的抗体药物偶联物，其有效载荷为拓扑异构酶I抑制剂，在HER2/neu表达的子宫癌和卵巢癌肉瘤中显示出抗肿瘤活性。

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2022.12.018
Mauricio, Dennis; Bellone, Stefania; Mutlu, Levent; McNamara, Blair; Manavella, Diego D; Demirkiran, Cem; Verzosa, Miguel Skyler Z; Buza, Natalia; Hui, Pei; Hartwich, Tobias Max Philipp; Harold, Justin; Yang-Hartwich, Yang; Zipponi, Margherita; Altwerger, Gary; Ratner, Elena; Huang, Gloria S; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Schwartz, Peter E; Santin, Alessandro D
肿瘤
肿瘤免疫
HER2
卵巢癌
发表日期：2023
文献求助 收藏

Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios

在复杂的解剖和临床场景中植入第二代生物可吸收血管支架的可行性研究

期刊:Clinical Research in Cardiology
影响因子:3.7
doi:10.1007/s00392-014-0757-4
Jaguszewski, Milosz; Ghadri, Jelena-Rima; Zipponi, Manuel; Bataiosu, Dana Roxana; Diekmann, Johanna; Geyer, Verena; Neumann, Catharina Anna; Huber, Mia Aurelia; Hagl, Christian; Erne, Paul; Lüscher, Thomas F; Templin, Christian
发表日期：2015
文献求助 收藏